NRC — Human Health Therapeutics Research Centre

Eligible expenses

This grant supports initiatives aimed at advancing biologics development and production, with a focus on tackling complex health challenges. Eligible projects include collaboration across research and development, innovative production processes, and therapy advancements.

• Design and development of innovative biologics for emerging infections, cancer, and neurological diseases.
• Biomanufacturing improvements to optimize production processes for complex biologics.
• Advancement of cell and gene therapies through collaborative projects.
• Preclinical research and development utilizing in vivo and in vitro testing.
• Scaling up bioprocesses for clinical trial material production compliant with GMP.
• Collaborative research initiatives to combat antimicrobial resistance.
• Development of CAR T-cell cancer therapies made in Canada.

Here are additional relevant details for this grant:

• Collaboration with industry, hospitals, health networks, academia, and government is encouraged to advance novel biologics.
• Access to multidisciplinary expertise and leading-edge facilities is available for the biologics development process, from discovery to clinical material production.
• Support for generating high-potential candidates using advanced proprietary technologies is provided.
• Preclinical R&D capabilities include small-scale manufacturing and both in vivo and in vitro testing expertise.
• Bioprocess improvements can be conducted in specialized R&D labs focusing on analytics, modelling, and intensification.
• Production facilities are available for optimizing bioprocesses and producing clinical trial materials compliant with good manufacturing practices (GMP).
• A directory of science professionals and researcher profiles is accessible, offering insights into their projects and expertise.